Updated - Affymetrix to Webcast Presentation at the Nasdaq 17th Investor Program Healthcare Forum
June 16 2006 - 7:31PM
Business Wire
Affymetrix, Inc. (Nasdaq:AFFX) today announced that Greg Schiffman,
Executive Vice President and CFO, will provide a company overview
at the Nasdaq 17th Investor Program Healthcare Forum in London, UK.
A live transmission of the presentation will take place at 9:15
a.m. local time (4:15 a.m. ET) on Wednesday June 21, 2006. An
archived webcast will be available for 30 days. To access the live
webcast or archived presentation, find the "Investors" link in the
"Resources for" drop-down menu on www.affymetrix.com. About
Affymetrix Affymetrix scientists invented the world's first
high-density microarray in 1989 and began selling the first
commercial microarray in 1994. Since then, Affymetrix GeneChip(R)
technology has become the industry standard in molecular biology
research. Affymetrix technology is used by the world's top
pharmaceutical, diagnostic and biotechnology companies as well as
leading academic, government and not-for-profit research
institutes. More than 1,400 systems have been installed around the
world and nearly 4,000 peer-reviewed papers have been published
using the technology. Affymetrix' patented photolithographic
manufacturing process provides the most information capacity
available today on an array, enabling researchers to use a
whole-genome approach to analyzing the relationship between
genetics and health. Affymetrix is headquartered in Santa Clara,
Calif., with manufacturing facilities in Sacramento, Calif., and
Bedford, Mass. The company maintains important sales and marketing
operations in Europe and Asia and has about 1,100 employees
worldwide. For more information about Affymetrix, please visit the
company's website at www.affymetrix.com. NOTE: Affymetrix, the
Affymetrix logo, and GeneChip are registered trademarks owned or
used by Affymetrix, Inc.
Affymetrix (NASDAQ:AFFX)
Historical Stock Chart
From Jun 2024 to Jul 2024
Affymetrix (NASDAQ:AFFX)
Historical Stock Chart
From Jul 2023 to Jul 2024